MétaCan
Menu
Back to cohort
Record W2121788941 · doi:10.1186/1710-1492-10-50

Canadian hereditary angioedema guideline

2014· article· en· W2121788941 on OpenAlexafffundvenueabout
Stephen Betschel, Jacquie Badiou, Karen Binkley, Jacques Hébert, Amin Kanani, Paul K. Keith, Gina Lacuesta, Bill Yang, Emel Aygören‐Pürsün, Jonathan A. Bernstein, Konrad Bork, Teresa Caballero, Marco Cicardi, Timothy Craig, Henriette Farkas, Hilary Longhurst, Bruce L. Zuraw, Henrik Balle Boysen, Rozita Borici‐Mazi, Tom Bowen, Karen Dallas, John Mark Dean, Kelly Lang‐Robertson, Benoît Laramée, Eric Leith, Sean R. Mace, Christine McCusker, Bill Moote, Man‐Chiu Poon, Bruce Ritchie, Donald Stark, Gordon Sussman, Susan Waserman

Bibliographic record

VenueAllergy Asthma and Clinical Immunology · 2014
Typearticle
Languageen
FieldMedicine
TopicCoagulation, Bradykinin, Polyphosphates, and Angioedema
Canadian institutionsUniversity of AlbertaSAIT PolytechnicUniversité LavalBC Children's HospitalCentre Hospitalier de l’Université de MontréalSaskatchewan Health AuthorityCanadian Association of GastroenterologyUniversity of CalgaryMcGill University Health CentreUniversity of OttawaUniversity of British ColumbiaWestern UniversityUniversity of TorontoDalhousie UniversityQueen's UniversityMcMaster University
FundersGenentechGrifolsSwedish Orphan BiovitrumCanadian Blood ServicesCSL BehringTeva Pharmaceutical IndustriesBioCrystViropharmaSanofi
KeywordsHereditary angioedemaGuidelineMedicineIntensive care medicineDiseaseAngioedemaQuality of life (healthcare)Health careFamily medicineNursingInternal medicineDermatologyPathology

Abstract

fetched live from OpenAlex

Hereditary angioedema (HAE) is a disease which is associated with random and often unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa, genitals, face and upper airway. Attacks are associated with significant functional impairment, decreased Health Related Quality of Life, and mortality in the case of laryngeal attacks. Caring for patients with HAE can be challenging due to the complexity of this disease. The care of patients with HAE in Canada is neither optimal nor uniform across the country. It lags behind other countries where there are more organized models for HAE management, and where additional therapeutic options are licensed and available for use. The objective of this guideline is to provide graded recommendations for the management of patients in Canada with HAE. This includes the treatment of attacks, short-term prophylaxis, long-term prophylaxis, and recommendations for self-administration, individualized therapy, quality of life, and comprehensive care. It is anticipated that by providing this guideline to caregivers, policy makers, patients and their advocates, that there will be an improved understanding of the current recommendations regarding management of HAE and the factors that need to be considered when choosing therapies and treatment plans for individual patients. The primary target users of this guideline are healthcare providers who are managing patients with HAE. Other healthcare providers who may use this guideline are emergency physicians, gastroenterologists, dentists and otolaryngologists, who will encounter patients with HAE and need to be aware of this condition. Hospital administrators, insurers and policy makers may also find this guideline helpful.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.716
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.295
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations84
Published2014
Admission routes4
Has abstractyes

Explore more

Same venueAllergy Asthma and Clinical ImmunologySame topicCoagulation, Bradykinin, Polyphosphates, and AngioedemaFrench-language works237,207